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 Abstract 
 
Movement disorders arise from the complex interplay of multiple changes to neural circuits. Successful 
treatments for these disorders could interact with these complex changes in myriad ways, and as a 
consequence their mechanisms of action and their amelioration of symptoms are incompletely 
understood. Using Parkinson’s disease as a case-study, we review here how computational models are a 
crucial tool for taming this complexity, across causative mechanisms, consequent neural dynamics, and 
treatments. For mechanisms, we review models that capture the effects of losing dopamine on basal 
ganglia function; for dynamics, we discuss models that have transformed our understanding of how 
beta- band (15-30 Hz) oscillations arise in the parkinsonian basal ganglia. For treatments, we touch on 
the breadth of computational modelling work trying to understand the therapeutic actions of deep brain 
stimulation. Collectively, models from across all levels of description are providing a compelling account 
of the causes, symptoms, and treatments for Parkinson’s disease. 
 
 
Introduction  
 
The basal ganglia are implicated in a wide range of movement disorders, especially Parkinson’s disease, 
Huntington’s disease, and dystonia. The causes and progression of these disorders are complex, arising 
from the interplay between multiple changes to neural circuits, and between those changes and 
consequent compensatory mechanisms in the brain. The link between these changes and the resultant 
overt clinical manifestations is incompletely understood. Available treatments are of limited efficacy and 
often have poorly defined mechanisms of action. As we aim to show here, one route out of this thicket 
is to use computational models as a guide to our often faulty intuition 
Parkinson’s disease exemplifies these issues, and will be our focus here. Classically, the onset of its 
cardinal signs (bradykinesia/akinesia, tremor, and rigidity) correlates with the loss of midbrain dopamine 
neurons projecting to the dorsal striatum, and especially the putamen in humans. This has long 
suggested a role for the basal ganglia in motor control, and pointed to aberrant basal ganglia dynamics 
as the root cause of the cardinal motor features. But the basal ganglia are a densely connected web of 
nuclei (Figure 1A). Any change to one neural population in the basal ganglia will have effects that ripple 
throughout its components; changes to more than one population are impossible to predict with any 
confidence. Consequently, there is a need for computational models of the parkinsonian basal ganglia to 
aid our understanding. 
There is a rich history of computational modelling of the basal ganglia’s dynamics in their healthy 
state, and of their changes under parkinsonian conditions [1–3]. Here we review key insights from such 
modelling in understanding neural mechanisms of the disease and its symptoms, how its aberrant 
neural dynamics arise, and how its treatments work. 
 
 
Consequences of dopamine depletion in the striatum 
 
We begin with the striatum. The striatum contains the densest expression of dopamine receptors in the 
vertebrate brain [4, 5]. The putamen is also the target of the most vulnerable set of midbrain dopamine 
neurons in Parkinson’s disease [6]. Thus anyone interested in understanding the causes of motor deficits 
in Parkinson’s disease is naturally drawn to understanding the effects of dopamine depletion on the 
striatum. 
 
Figure 1: Consequences of dopamine depletion in the striatum. 
A The basal ganglia nuclei and main connections (bar: inhibitory; arrow: excitatory). Striatum divides into 
two projection neurons populations expressing D1 and D2 type receptors for dopamine. Routes from the 
D1 and D2 populations to the output nuclei (GPi) have historically been labelled the “direct” and 
“indirect” pathways. For clarity, we omit here some pathways, including the projection from GPe to the 
striatum, and the local connections within the striatum. STN: subthalamic nucleus; GPe: globus pallidus, 
external segment; GPi: globus pallidus, internal segment. 
B Single neuron models predict that dopamine differentially affects the excitability of D1 and D2- receptor 
expressing projection neurons. Consequently, dopamine depletion reduces excitability of D1-expressing 
neurons, and increases the excitability of D2-expressing neurons. Redrawn from [13]. 
C Distributions of the correlations between spontaneous neuron firing in intact and dopamine- depleted 
striatal network models [16]. The models predict that the spontaneous activity of the intact network is 
sparse, irregular and uncorrelated; but that dopamine depletion creates spontaneous activity that is 
anti-correlated (negative correlations). Such changes within the striatum’s dynamics are in addition to any 
changes to the drive or synchrony of its cortical input caused by dopamine depletion. 
D Schematics showing how network models of the basal ganglia predict a breakdown of action selection 
in Parkinson’s disease [cartoon of the results in e.g. 18, 20, 23]. Under normal conditions, a phasic input to 
the basal ganglia from cortex (top) produces (middle) a transient suppression of activity in a small group 
of GPi neurons (blue); this transient suppression of inhibition allows “selection” to occur by disinhibiting 
the thalamic and brainstem targets of these GPi neurons. Following dopamine depletion (bottom), the GPi 
activity barely changes in response to the same input, thus slowing or preventing action selection. 
 
The effects of dopamine receptor activation on a single striatal neuron are subtle and complex [7–9]. 
Experimental studies of the striatal projection neuron have established how dopamine receptor 
activation down- and up-regulates a suite of ion channels, both inside and outside of synapses [7], to 
control the excitability of the neuron. Understanding the interplay between all these effects has 
required detailed models of single projection neurons that synthesise the findings of many experimental 
studies [10–12]. One contribution of these models has been to provide an intuitive picture of the net 
effect of activating either D1 or D2 type dopamine receptors, and show that these effects cause D1 and 
D2 expressing projection neurons to respond differently to excitatory input [13]. They thus predict that 
the net effect of dopamine depletion is to change the excitability of projection neurons in opposite 
directions depending on their expression of D1 or D2 type dopamine receptors (Figure 1B). Such models 
have shown that intuitive arguments about Parkinson’s disease changing the balance of the direct and 
indirect pathways [14, 15] have a biophysical basis. 
Consistent with the changes to individual neuron dynamics, models of the whole striatal network 
predict that dopamine depletion profoundly disrupts its normal dynamics. One study suggests that 
dopamine-depletion increases the spontaneous correlations between projection neuron firing [16]; such 
spontaneous correlated activity could potently block cortical input from being transmitted to striatum 
and onto the rest of the basal ganglia (Figure 1C). Another study suggests that dopamine depletion 
alters the balance of D1 and D2 projection neuron activity by changing the output of the sparse but 
powerful inhibitory interneurons [17]. Both point to the need to understand how network-scale changes 
in Parkinson’s disease arise from the cumulative effects of dopamine depletion on individual neurons. 
At a broader scale still, models of the whole basal ganglia network have sought to understand the 
knock-on effects of the depletion of dopamine in the striatum. Many such models test the theory that 
the basal ganglia’s normal function is to perform action selection through the interaction of the direct 
and indirect pathways [18, 19]. Dopamine depletion in these models disrupts the balance of the two 
striatal output pathways, leading to action selection deficits [20-22]. The imbalance could arise either 
through direct effects on neural excitability, as reviewed above, or through aberrant cortico-striatal 
plasticity that follows dopamine depletion [21]. Other models suggest a disruption between the balance 
of direct and cortico-subthalamic (or “hyperdirect”) pathways by dopamine depletion [21,23]. Whatever 
the mechanism, all these models predict a jamming of basal ganglia output, because the direct pathway 
can no longer induce sufficient inhibition of the basal ganglia output (Figure 1D). This lost ability to 
voluntarily select actions is consistent with the akinetic and bradykinetic features of Parkinson’s disease. 
 
 
Modelling the effect of losing dopamine neurons on the concentration of 
dopamine and on D1 and D2 signalling 
 
While the above models seek the consequences of dopamine depletion on the dynamics of the striatum 
and wider basal ganglia network, others have pursued the equally profound question of how the loss of 
midbrain dopamine cells creates a complex landscape of adaptations to that loss and subsequent 
changes in dopamine dynamics during the development of Parkinson’s disease. They suggest that a 
more nuanced approach is needed to understand the effects of dopamine loss on striatum, and thus on 
basal ganglia function. 
One of the simplest but potentially far-reaching predictions of these release models is the 
phenomenon of passive stabilisation [24]. Kinetic models of dopamine release are often used to 
simulate the interplay between dopamine release and re-uptake [25, 26]. The loss of dopamine 
terminals in Parkinson’s disease simultaneously causes a reduction in vesicular release of dopamine and 
in its re-uptake. Kinetic models predict that the loss of release and of re-uptake are exactly balanced, 
and as a consequence there is little change in steady-state dopamine tone following the loss of 
dopamine terminals [24, 27]. This passive stabilisation of dopamine tone is even more robust if the 
effects of dopamine autoreceptors on the terminals are simulated, because the autoreceptors act as 
negative feedback on vesicle release [28]. Passive stabilisation of dopamine tone is also seen in detailed 
reaction- diffusion models of dopamine release that emulate the volume transmission of dopamine 
throughout a three-dimensional region of the striatum (Figure 2A) [29–31]. Thus several lines of 
modelling predict that passive stabilisation maintains a normal dopamine tone despite the loss of 
dopamine neurons (Figure 2B-C). 
 
Figure 2: Modelling of dopamine volume transmission after cell loss. 
A Modelling dopamine release, diffusion, and re-uptake in volumes of the striatum [29–31]. For a 20 
micrometre cube of simulated striatum, we show the simulated density of dopamine release sites in healthy 
tissue (left) and after losing 90% of dopamine terminals (middle). Simulating dopamine release from all sites 
results in heterogeneous dopamine concentration throughout the volume (color-scale in nM). 
B Simulated effects of bursts and pauses in dopamine cell firing on dopamine concentration (top). The average 
concentration of dopamine (dopamine tone) is maintained around 40 nM throughout. Alternating bursts 
(green asterisks) and pauses (red asterisk) in spike firing cause phasic peaks and dips in dopamine 
concentration. These consequently activate dopamine receptor-dependent intracellular signals via D1 (green, 
middle) and D2 (red, bottom) receptors: D1 receptors read-out peaks; D2 receptors read-out dips. Insets show 
averaged responses around each burst or pause (individual responses in grey). 
C As panel B, for a volume with 85% loss of dopamine release sites. Despite the severe loss, passive 
stabilisation means that the average concentration of dopamine is unchanged. By contrast, changes in 
dopamine concentration during bursts and pauses are now barely discernible from random fluctuations in the 
background dopamine tone (top). Consequently, the model predicts that D1 and D2 receptor dependent 
signals will be similar between periods of background tone and periods of phasic events (middle and bottom). 
 
Passive stabilisation seemingly provides a simple hypothesis [24, 27] for why the cardinal signs of 
Parkinson’s disease develop after substantial loss of midbrain dopamine neurons. The motor features of 
Parkinson’s disease are often thought to be a consequence of a gradual loss of dopamine tone; from this 
perspective, the delayed appearance of the motor signs of Parkinson’s disease could be explained as a 
consequence of this passive stabilisation of dopamine tone. 
This cannot though be the whole story. Whereas post-mortem and imaging studies estimate that a 
loss of dopaminergic neurons and terminals on the order of 50% correlates with the emergence of 
parkinsonian motor features [6, 32], detailed volume transmission models predict that dopamine tone 
would still be stabilised with a nearly complete loss of dopamine neurons and terminals [31, 33]. As an 
example, Figure 2C shows these models predict that losing 85% of the dopamine terminals has no 
detectable effect on dopamine tone. Volume transmission models instead predict that the onset of the 
cardinal signs of Parkinson’s disease is a consequence of the degraded phasic variations in dopamine 
concentration against this stabilised background tone. 
Phasic variations in dopamine concentration arise because dopamine neurons deviate around their 
constant spontaneous activity with brief bursts or pauses (Figure 2B). These phasic changes in firing can 
be elicited by unexpected rewards and events [34–36], which may act as a teaching signal that controls 
synaptic plasticity in the striatum [37–40]. Phasic changes in both the firing of dopamine neurons in the 
lateral substantia nigra pars compacta [S41] and the activity of dopaminergic axons in the dorsal 
striatum [S42] also correlate with movement. Volume transmission models of dopamine in the intact 
striatum show that these bursts and pauses in activity are translated with high fidelity into phasic 
increases and decreases in dopamine concentration [29, 30] (Figure 2B) . However, they also show that 
the loss of dopamine terminals inevitably decreases how effectively bursts and pauses of activity can 
change dopamine concentration (Figure 2C) [31]. 
These models predict that because the dopamine tone is passively stabilised, but phasic changes in 
dopamine are blunted, so the phasic variations become more difficult to distinguish from mere 
fluctuations in dopamine tone as more dopamine neurons are lost. This reduction in the signal-to-noise 
ratio of phasic dopamine becomes notable at moderate loss of dopamine terminals, consistent with the 
predicted scale of loss of dopamine neurons and terminals at which parkinsonian motor features are 
first observed [6, 32, S43]. The models predict that it finally becomes impossible to distinguish phasic 
events from random fluctuations in baseline dopamine tone at around 80% loss of terminals [31] (Figure 
2C). In addition, as the magnitude of the phasic variations in dopamine decrease with the loss of 
dopamine neurons, so the dopamine receptors are likely to increase their sensitivity to compensate. The 
combined effect of reduced signal-to-noise ratio and increased receptor sensitivity is thus predicted to 
be aberrant activation of the D1 and D2 receptors, uncoupled from external events. 
This aberrant activation has potentially many functional consequences. On the one hand, 
dopamine-mediated teaching signals would be missed, or random fluctuations treated as teaching 
signals, both leading to aberrant synaptic plasticity in striatum. On the other, if phasic variations in 
dopamine act as a signal to initiate movement [S41,S42], then losing the ability to detect phasic changes 
would slow or impair the initiation of movement. 
The volume transmission models also predict that the breakdown of passive stabilisation after 
massive loss of terminals is not homogeneous, as it creates isolated volumes of tissue that contain no 
dopamine innervation [31]. These dopamine voids are predicted to create local imbalances in striatum, 
as neurons within neighbouring regions of intact and depleted dopamine interact. The volume 
transmission models thus point to a dual faced nature of dopamine denervation in Parkinson’s disease, 
first through loss of phasic dopamine dynamics and later through the creation of dopamine voids, raising 
the possibility that symptoms and signs arise by these different mechanisms acting concurrently in 
different areas of the striatum. 
A key insight from computational models is that striatal neurons expressing the D1 and D2 receptors 
are differentially sensitive to the loss of dopamine terminals [11]. Modelling suggests that D1 receptors 
will respond strongly to phasic peaks in dopamine concentration, driven by bursts of spikes at up to 30 
Hz; by contrast, models predict that D2 receptors respond to phasic dips in dopamine concentration, 
driven by pauses in the 4Hz spontaneous rate of spiking [11, 12]. As these downward deflections in firing 
rate are bound below by zero, so the D2 receptors have a worse signal-to-noise ratio for detecting 
phasic dopamine events even in the intact striatum (Figure 2B). Consequently, models predict that D2 
receptors will be more sensitive to the loss of dopamine terminals [31, 33,S41]. These predictions are 
consistent with the early remodelling of D2-expressing striatal projection neurons in rodent models of 
Parkinson’s disease [S44]. 
Detailed kinetic models also allow us a better understanding of L-DOPA’s therapeutic actions and 
side-effects. Network models of the striatum simulate L-DOPA as a global increase in dopamine [19, 21, 
S45]. Such models predict that a side-effect of L-DOPA would be to raise dopamine tone above normal 
levels in striatal regions that had not lost dopamine terminals. Detailed release models more accurately 
simulate L-DOPA as an increase in the number of dopamine molecules released by vesicles in remaining 
terminals [31, 33]. In direct contrast to the network models, these release models predict little effect in 
healthy regions of the striatum due to autoreceptors regulating release at dopamine terminals. In 
dennervated regions, release models predict that L-DOPA’s increase of vesicles allows both partial 
restoration of dopamine tone and improved separation of phasic dopamine release from background 
tone [31]. As these models also capture homeostatic changes in receptor sensitivity, a future avenue for 
work could be to examine the consequences of on-medication periods for dopamine signalling in 
subsequent off-medication periods, in order to dig deeper into the origins of L-DOPA’s side-effects. 
 
 
Mechanisms of Parkinsonian neural oscillations 
 
Our clearest glimpse of the neural dynamics in the parkinsonian basal ganglia has come from recordings 
obtained during surgery to implant electrodes for deep brain stimulation. Recordings from such 
electrodes placed in the subthalamic nucleus have revealed a prominent 15-30 Hz “beta-band” 
oscillation in the local field potential, a signature of co-ordinated synaptic activity [S46, S47]. The 
strength of beta-band oscillation correlates with motor-deficit severity, is suppressed by 
dopamine-replacement medication, and the magnitude of its suppression is correlated with the degree 
of improvement in movement [S48,S49]. Consequently, the questions of how and where such an 
oscillation arises have driven a rich vein of modelling work. 
Modellers have pursued three broad hypotheses for the origin of the beta-band oscillation. The first 
and most popular has been the negative feedback loop between the excitatory subthalamic nucleus 
(STN) and the inhibitory external globus pallidus (GPe). Modellers have long found this loop intriguing 
because delayed negative feedback loops are a classic electrical circuit design for oscillators; perhaps 
unsurprisingly, models of the STN-GPe loop have been shown to generate oscillations under a wide 
range of conditions, both healthy and parkinsonian [20, S50–S52]. 
By what mechanisms does this loop produce oscillations under parkinsonian conditions of dopamine 
depletion? Models have uncovered multiple mechanisms that can cause this loop to shift from stable to 
oscillatory activity [22], but two have been prominently explored because they could plausibly follow 
from the loss of dopamine. One mechanism is the strengthening of the effect of input from D2-receptor 
striatal projection neurons to the pallidum [S50], possibly due to the increased excitability of D2 
projection neurons (which is a predicted consequence of dopamine loss, as noted above). The second 
mechanism is the strengthening of the connections between STN and GPe [20], possibly because 
pre-synaptic D2 receptors that prevent transmitter release in these nuclei are no longer activated after 
dopamine depletion [20]. Either alone or in combination, both these mechanisms switch the STN-GPe 
loop from stable to oscillating. 
 
While there are many routes to making the STN-GPe loop oscillate, models have shown that 
specifically producing oscillations in the beta-band requires a more limited set of conditions. Analytical 
models from Bogacz and colleagues [S53,S54] showed that beta- band oscillations can arise if the total 
delays in transmission between the STN and GPe are set within a narrow range. Biophysical models of 
the STN-GPe loop also require setting specific transmission delays to obtain beta-band oscillations [S55]. 
This raised the question of whether the transmission delays in the real primate basal ganglia meet these 
conditions. Recently, building on their detailed model of primate basal ganglia [S56], Lienard and 
colleagues [S57] searched for the set of transmission delays that allowed their model to replicate a 
range of electrophysiological data in healthy primates. With their found set of delays in hand they then 
made their model parkinsonian, by increasing the strength of connections between STN and GPe, and 
beta-band oscillations emerged. Models thus show that beta-band oscillations in the basal ganglia of 
primates can emerge from the STN-GPe loop. But a challenge to this idea is that while rodent models of 
Parkinson’s also show beta-band oscillations within STN [S58], computational models suggest the STN- 
GPe loop in rodents naturally oscillates at higher frequencies [20]; this suggests beta-band oscillations in 
rodents have their origin outside the STN-GPe loop. 
Modellers have thus pursued a second hypothesis that proposes beta-band oscillations are 
generated by the full loop from cortex through the basal ganglia and back to cortex (via thalamus; Fig. 
1A). In these models, beta-band oscillations arise because dopamine depletion either changes basal 
ganglia control over the thalamo-cortical loop, causing it to oscillate at beta-band frequencies which are 
then input to the basal ganglia via cortex [S59–S61]; or it causes an imbalance between the two cortical 
loops running via the direct and hyperdirect pathways, which leads to a network-wide oscillation when 
the total gain in the hyperdirect pathway is sufficiently larger than in the direct pathway [23]. Either 
way, these models predict that such oscillations emerge from a diffuse network of brain structures, 
rather than a single loop. 
A third hypothesis is that beta-band oscillations emerge through changes within the striatum.  One 
plausible scenario explored by Damodaran and colleagues [S62] is that the change in balance of D1 and 
D2 projection neuron activity caused by dopamine depletion is matched by an increase in output from 
the inhibitory fast-spiking interneurons in order to down-regulate the projection neurons. The 
biophysical model of [S62] predicts that this causes the projection neurons to become entrained by 
interneuron output within the beta-band frequencies. Another plausible scenario is that 
dopamine-depletion leads to synchronised pauses in the fast-spiking interneuron activity that allow the 
projection neurons to burst at beta-band frequencies [S63]. These models have made plausible the idea 
of striatal-based mechanisms for the generation of oscillatory activity in the beta-band; it remains to 
show that these oscillations can then spread to the rest of the basal ganglia nuclei as observed in animal 
model and human patient recordings. 
The diversity of modelling explanations for the origin of beta-band oscillations reflects the 
complexity of the underlying circuit, with its multiple loops and varied neuronal dynamics. The diversity 
of models also reflects the need, oft-ignored, to be careful in specifying which species is being modelled. 
After all it is clear that the oscillations in the STN differ between human patients, rodents with their 
equivalent 15-30 Hz beta-band that requires large unilateral lesions of dopamine neurons to obtain 
[S58,S64], and primates with their “low” beta-band (< 15 Hz) in the MPTP model of Parkinson’s disease 
[S65]. Indeed it seems likely that different species will have different underlying causes for their 
beta-band oscillations, not least because the transmission delays between the basal ganglia nuclei scales 
with the size of the brain. Some explicit species-specific models of rodent [20, 22] and primate [S56] 
basal ganglia exist, providing a foundation with which to meet this challenge. A further challenge is that 
not all patients display beta-band oscillations; thus there remains considerable theoretical work needed 
to link the presence of such oscillations to specific symptoms.  
 
 
Mechanisms of deep brain stimulation therapy for Parkinson’s disease 
 
The now routine use of deep brain stimulation for treating the cardinal motor signs of Parkinson’s 
disease has proved remarkably effective. But this effectiveness has raised a host of questions over its 
mechanisms of action and effects on the brain, questions that have inspired many computational 
modelling efforts. The majority of these models have studied high frequency stimulation of the STN, as 
this has emerged as the primary clinical target for deep brain stimulation therapy. 
One class of models have sought to separate the hypotheses of deep brain stimulation exciting or 
inhibiting (functionally lesioning) the neurons in the target region [S66]. To do so, these models have 
studied the effects of simulated deep brain stimulation current pulses on a detailed model of a single 
neuron and its axon cable (see [1] for further review). The models have primarily revealed axonal effects 
[S67], whereby the stimulation pulses entrain action potentials directly in the axons immediately 
surrounding the electrode. Such models predict that deep brain stimulation thus regularises the output 
of the STN. 
 
Figure 3: Model insights into the mechanisms of STN deep brain stimulation. 
A Schematic of regularisation theory [S68]. Left: models predict that, under parkinsonian conditions, the burst 
firing of GPi neurons, driven by STN burst firing, prevents the transmission of information through the 
thalamus. In this example, the thalamic output spike train is both missing spikes and produces additional 
spikes (orange) compared to the input. Right: when simulated high-frequency stimulation is applied to the STN 
(red spikes), the consequent regularisation of the GPi output restores transmission through the thalamus. 
B Mixture theory, after [S71]. Left: network-scale models simulate a three-dimensional spread of current 
around the stimulating electrode (red) in STN, schematically illustrated here for a cube of STN neurons. 
Grey-scale shading is proportional to the magnitude of current received by each neuron from the central 
electrode (darker shading indicates more current). Middle: as a consequence, turning on the stimulation 
causes a mixed response in the STN, which leads in turn to a range of neuron firing patterns in GPi and GPe 
(raster plot: one row per neuron, each dot is one spike). Right: the network models predict that sustained 
high-frequency stimulation leads to a mixture of responses in GPi output, for which we show three example 
neurons: excited (top), inhibited (middle), and unaffected (bottom). The proportions of each response in the 
network model match those seen in therapeutic high-frequency stimulation in primates [S73]. 
 
Many models have explored the effects of high-frequency stimulation of the STN on the STN-GPe 
loop, and how their combined output in turn alters GPi output to thalamus. One notable class of models 
here embodies the theory that high-frequency entrainment of the STN ultimately restores function to 
the thalamus by regularising GPi output [S68, S69]. These models show that the parkinsonian bursting 
activity in STN and GPe is transmitted through the GPi to thalamus, and disrupts the passing of 
information through thalamus (Fig. 3A). They predict that high-frequency entrainment of STN neurons in 
turn entrains GPi output to the same regular frequency; the suppression of GPi burst firing restores 
information transmission through the thalamus (Fig. 3A). 
Another set of models have looked at the heterogenous effects of STN high-frequency stimulation 
when scaling up to the whole network [S70]. These models start from the idea that within a volume of 
tissue the strength of stimulation drops off with distance from electrode [S70], and so the response of 
the simulated STN neurons is heterogeneous [S71, S72] (In contrast, the STN-GPe models exploring the 
regularisation hypothesis are typically very small, and assumed homogeneous activation of STN by the 
electrode). Such heterogeneous responses in simulated STN lead to heterogeneity in the changes to the 
firing and burst rate of GPi neurons [S71, S72], which replicate the heterogeneity of changes recorded 
from primate GPi during high-frequency stimulation of the STN [S73, S74]. The model of [S71] predicts 
that deep brain stimulation of the STN restores a natural output balance to the GPi (Fig. 3B), because 
these heterogeneous responses in STN ultimately restore the balance of excitatory (via STN) and 
inhibitory (via GPe) input to GPi neurons. A similar effect of restoring the balance of STN and GPe input 
to GPi was replicated in a recent detailed biophysical model [S61]. These network-scale models also 
provide a clue as to why 100 Hz is typically the minimal clinically-effective stimulation frequency: only 
above this frequency did a significant proportion of simulated GPi neurons become restored to their 
pre-parkinsonian state [S61, S71]. 
Recent theoretical work has added an important new idea: short-term depression. Experiments 
using high-frequency stimulation of the STN in rodents and primates report both a decreased magnitude 
and increased latency of response in targets of the STN over the duration of the stimulation [S75]. Rubin 
and colleagues [S75] showed they could account for these experimental results using a model in which 
each stimulation pulse causes a short-term depression in the likelihood of both STN axonal spikes and 
synaptic release in response to future pulses. The model predicts that under high-frequency stimulation 
this short-term depression is cumulative, leading to the observed reduction in response and increased 
latency in the STN’s targets. Importantly, their model predicted that such short-term depression would 
suppress the transfer of low-frequency oscillations from the STN to the GPe and GPi, by preventing STN 
axonal spiking from tracking oscillatory input to the STN. Confirming this prediction, they showed their 
model of short-term depression replicated the suppression of beta-band oscillations in the GPi by 
high-frequency stimulation of the STN in MPTP primates [S76]. If correct, this theory of short-term 
depression has potential to inform more efficient designs of therapeutic stimulation patterns. 
The diversity of modelling approaches here reflects the multi-scale nature of understanding deep 
brain stimulation. These models run the gamut from the effects of stimulation on a single axon, through 
to detailed models scaling up these predicted regularisation effects to the scale of a small network, and 
on to larger network models that deal with the inevitable heterogeneity of effects on the scale of entire 
nuclei. The regularisation and network models make different predictions for the therapeutic 
mechanism of deep brain simulation. In principle, these could be tested with optogenetic mimicking of 
the patterns of STN neuron recruitment in animal models. However, this would require development of 
opsin channels that can track the high frequencies needed for therapeutic deep brain stimulation, and 
so produce time-locked action potentials at 90 Hz and above. (Unfortunately, prior work using 
optogenetics to mimic deep brain stimulation [S77] was uninformative, as the opsin used could not track 
stimulation above 70Hz [S71]). A further hypothesis yet to be explored by computational models is that 
deep brain stimulation of the STN achieves its therapeutic action by antidromic stimulation of motor 
cortex [S78, S79]. 
 
 
Open questions, and fruitful paths 
 
The computational modelling work we have reviewed reflects two different modelling philosophies. In 
one philosophy, models are constructed based on ideas of neural function, and then biophysical changes 
wrought by a disorder are emulated and the consequences for that function observed. Here we have 
seen that models of how the basal ganglia control action selection and decision-making develop 
Parkinson’s like changes following emulated dopamine depletion. In the other philosophy, the goal of 
the models is to understand the dynamics of neurons under disease, as a prelude to treating those 
dynamics, irrespective of the function they subserve – such as the models of beta-band oscillations. 
Both philosophies contribute to our ultimate goal of understanding the mechanisms of Parkinson’s 
disease and its effective treatments. 
Many puzzles remain in our understanding and treatment of Parkinson’s disease [S80]. One is what 
other targets of treatment within the basal ganglia are viable. In a recent bio- physical basal ganglia 
model, Lindahl and Hellgren-Kotaleski [22] explored this question. Dopamine depletion produced 
synchrony and oscillations throughout their model: their innovative approach was to then systematically 
test which changes to the model damped these oscillations and synchrony. One insight was that, 
because this model assumed a cortically-generated source for the beta-band oscillations, it predicted an 
increase in the strength of cortical input to the D2 projection neurons would suppress the transmission 
of beta-band oscillations through the basal ganglia. In contrast, the models that hypothesise an origin of 
beta oscillations in the STN-GPe loop predict that the same increase in strength would worsen 
beta-band oscillations. Collectively, these models have thus identified a potentially key deciding 
parameter between the theories of how beta-band oscillations are generated. 
 
There are many other puzzles amenable to computational insights, of which we touch on a few here: 
 
• Dopamine is depleted throughout the basal ganglia, not just in striatum – what are the effects of 
this extra-striatal loss of dopamine? One hypothesis arising from modelling work is that 
dopamine actively decouples the STN-GPe loop [20]; its recoupling by the loss of dopamine 
could be a main cause of beta-band oscillations [S53]. The effects of dopamine depletion on 
plasticity at synapses outside the striatum are also largely unexplored [but see ref. 21].  
 
• How do realistic changes in dopamine release, predicted by detailed models [33], affect the 
neural dynamics of the basal ganglia? What are the predicted functional consequences? 
 
• What effect does lesion surgery for the treatment of Parkinson’s disease [S81,S82] have on the 
dynamics of the basal ganglia and wider cortico-basal ganglia loops? Computational models 
have yet to properly address the consequences of lesions on the dynamics of the Parkinsonian 
basal ganglia. Partly this is because the effects would be trivially catastrophic in most models – 
removing an entire nucleus (such as the GPi) would not restore normal dynamics, but render the 
model non-functional because it pushes the basal ganglia’s dynamics far from the healthy state. 
For example, in all the models of beta-band oscillations reviewed above it is trivially obvious 
that removing the STN would stop the beta oscillations. But it would also trivially move the 
dynamics of the GPe (and GPi) very far from the nominally healthy state. Thus, from a 
computational perspective, why lesion surgery is effective is as much a mystery as deep brain 
stimulation. One potential line of investigation is that the restoration of motor function after 
unilateral lesion implies some inter-hemispheric process restoring normal brain dynamics [S83] - 
yet we know little about, and so have no models of, inter-hemispheric interactions of the basal 
ganglia. Another line of investigation, explored in a few studies to date [21, S84], is that lesions 
are not trivially destructive if crucial mechanisms, such as learning, take place outside the basal 
ganglia; in these studies, lesioning of a basal ganglia nucleus from a Parkinsonian model restores 
some capacity to learn.  
 
• How are the loss of dopamine and the changes in neural dynamics coupled over time? Typically, 
computational models are switched between discrete baseline and Parkinsonian states. 
However, dopamine neurons are lost continually, and the compensatory mechanisms that 
evokes are likely also continuous. Studies in animal models over the course of dopamine loss as 
they are rendered Parkinsonian have suggested a complex temporal relationship between the 
loss of dopamine neurons and the emergent changes in oscillations, synchrony and firing rates 
[S85, S86], pointing to the need for computational models to make predictions about the causal 
sequence of neural changes. 
 
• How might we design more efficient forms of deep brain stimulation? Standard stimulation 
protocols, of a constant, regular train of pulses at above 100Hz, are both a blunt (if effective) 
tool, and wasteful of battery life. A solution would be some form of closed loop deep brain 
stimulation, in which key signatures of Parkinsonian dynamics are used to trigger stimulation 
pulses that suppress the aberrant dynamics. Both animal model studies [S87] and preliminary 
human trials [S88] have provided evidence that closed-loop deep brain stimulation could indeed 
be more effective than standard, open-loop, protocols. An alternative to closed-loop is better 
targeting of the stimulation; notable here is Peter Tass’ theoretical proposal of co-ordinated 
reset, where multiple locations randomly stimulated to reset pathological oscillations [S89] – 
which progressed to human proof-of-principle trials [S90]. Further computational modelling 
would be able to answer many questions here, including finding the best signatures for 
triggering closed-loop stimulation, and working out the most effective and efficient forms of 
that feedback stimulation.   
 
 
Models are intended to be abstractions of reality. To aid understanding, they intentionally omit 
detail, and simplify complex, messy biological mechanisms. They are eternally out of date: for example, 
the discovery of multiple neuron populations within the rodent GPe [S64, S91, S92], each making a 
distinct set of connections within the basal ganglia, has made the study of the beta-band oscillations far 
more complex [S93]. The goal of computational models is to be a crutch to our feeble understanding, by 
forcing us to turn words into exact meanings, to examine our assumptions, and to reach further than 
can our minds alone. 
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